Skip to content
Bamboo Works
Search
Sign in / Register
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • Infrastructure/Resources
    • Property
  • Fast News
  • Focus Companies
    • 360 DigiTech
    • Atrenew
    • Beigene
    • Cango
    • Daqo New Energy
    • Huazhu
    • Pop Mart
    • Tuya
    • Yalla
    • Yum China
  • Expert Corner
  • Premium Content
  • China ESG Focus
  • About Us
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • 简中
  • 繁中
  • Eng
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • Infrastructure/Resources
    • Property
  • Fast News
  • Focus Companies
    • 360 DigiTech
    • Atrenew
    • Beigene
    • Cango
    • Daqo New Energy
    • Huazhu
    • Pop Mart
    • Tuya
    • Yalla
    • Yum China
  • Expert Corner
  • Premium Content
  • China ESG Focus
  • About Us
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

Sinopharm

CSPC Pharma wins China’s mRNA vaccine race, but just not fast enough

Drugmaker CSPC Pharma gets the green light to produce China’s first homegrown mRNA vaccine, but the breakthrough comes too late in the pandemic to impress investors Key Takeaways: News of…
March 29, 2023
1093.HK

YSB’s B2B Pharma Platform: Sexier Than the SOEs, But Stodgier Than B2Cs

The drug distributor for pharmacies and community-level medical institutions has filed for a Hong Kong listing, boasting strong revenue growth but also massive losses Key Takeaways: YSB has filed for…
May 31, 2022

CanSino’s Covid Vaccine Gets WHO Nod. But Is It Too Little, Too Late?

The company’s Convidecia has received emergency-use authorization from the World Health Organization, becoming the third Chinese vaccine to get that nod Key Takeaways: CanSino’s Covid-19 vaccine Convidecia will be admitted…
May 26, 2022

AIM Puts mRNA Covid Vaccine in Investor Crosshairs With New IPO Attempt

Vaccine maker’s previous IPO bids on Shenzhen’s ChiNext board and in Hong Kong failed, but it is soldiering ahead with a new attempt in Hong Kong Key takeaways: Vaccine maker AIM…
April 18, 2022
B.US

Everest Boosts Covid Bet With New Licensing Deal Despite Crowded Field

Global agreement for oral anti-viral comes just months after company signed separate similar tie-up for a Covid mRNA vaccine also in development Key Takeaways Everest has signed a global licensing…
January 20, 2022

Everest Joins Race to Make mRNA Covid Vaccines for China

Company’s move comes as Beijing shows growing signs of approving the new type of high-tech vaccination Key takeaways: Everest will pay up to $150 million or more to potentially bring…
September 21, 2021

Recent Articles

March 29, 2023

CSPC Pharma wins China’s mRNA vaccine race, but just not fast enough

1093.HK
May 31, 2022

YSB’s B2B Pharma Platform: Sexier Than the SOEs, But Stodgier Than B2Cs

May 26, 2022

CanSino’s Covid Vaccine Gets WHO Nod. But Is It Too Little, Too Late?

April 18, 2022

AIM Puts mRNA Covid Vaccine in Investor Crosshairs With New IPO Attempt

B.US
January 20, 2022

Everest Boosts Covid Bet With New Licensing Deal Despite Crowded Field

September 21, 2021

Everest Joins Race to Make mRNA Covid Vaccines for China

Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo File-alt

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

Bamboo Works offers a range of partnerships for corporate and other partners, including opportunities for sponsored content, article-writing services and a wide range of promotions.

About Us
Focus Companies
Fast News
Expert Corner
Premium Content
Facebook Twitter Linkedin Weixin Weibo File-alt

Categories

  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • New Energy
  • IPO
  • Infrastructure/Resources

Newsletter

For all latest news, offers and special announcements.
Signup
Copyright © 2022 Bamboo Works. All rights reserved.